LSX World Congress Europe

LSX World Congress Europe

24 March – Pre-day forums (Life Science Companies only), FIL (Feira Internacional de Lisboa), | 25-26 March – Main days, Lisbon Congress Centre, Portugal

Empowering early-stage life science

Part of Life Science Week Europe

“Where global leaders in life sciences drive innovation, investment, & impactful collaborations.”
– Venture Development Manager, Biotech, NLC Health Ventures

LSX Europe is the continent’s premier life sciences fundraising and investment event, where innovation meets opportunity through strategic 1:1 meetings and targeted networking.

Early-stage biotechnology, medical devices, diagnostics, and digital health companies, including university spin-outs, are attending seeking investment and collaboration opportunities.

Active life science investors attend, looking for new investments and syndication.

Together through our proven partnering format, attendees engage in meaningful conversations that translate into real partnerships, and successful fundraising.

Join us to ‘Connect with Purpose’.


BioRN members receive a 10 % discount.

Please contact Nicole Hecht (nh(at)biorn.org) for the Discount Code and more Information.

register now

Our latest News

discover more
Weight Loss in Cancer: Organs Respond to the Disease in a Coordinated Way

Weight Loss in Cancer: Organs Respond to the Disease in a Coordinated Way

Cachexia is a metabolic disorder that causes uncontrolled weight loss and muscle wasting in chronic diseases and cancer. A new study by Helmholtz Munich, in collaboration with the Institute of Physiology of the Czech Academy of Sciences in Prague, Heidelberg University Hospital, the German Center for Diabetes Research (DZD), and the German Center for Cardiovascular […]

How cells control inflammatory responses

How cells control inflammatory responses

Inflammation has to work fast against pathogens—but it can’t get out of control. Researchers at the German Cancer Research Center (DKFZ) have now deciphered in more detail how the organism masters this balancing act. Their work shows that cells use two different strategies to precisely control inflammatory genes and thus precisely regulate the inflammatory response. […]

Highly endowed research award for DKFZ scientist

Highly endowed research award for DKFZ scientist

Daniel Kirschenbaum from the German Cancer Research Center (DKFZ) is developing new methods to find out exactly how immune cells are suppressed by malignant brain tumors. He is being supported in this by the EACR-Mark Foundation and the Pezcoller Foundation with the Rising Star Award, which is endowed with 100,000 euros. Tumor cells have a […]

GET IN TOUCH

Stay Updated with bioRN’s Newsletter

Sign up for our newsletter to discover more!
* required

BioRN (BioRN Network e.V. and BioRN Cluster Management GmbH) will use the information you provide on this form to be in touch with you and to provide updates and marketing. Please let us know all the ways you would like to hear from us:

You can update your subscription preferences or unsubscribe at any time. Just follow the unsubscribe or update link in the footer of automated emails you receive from us, or by contacting us at info@biorn.org. We will treat your information with respect. For more information about our privacy practices please visit our website: www.biorn.org. By clicking below, you agree that we may process your information in accordance with these terms.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.

Intuit Mailchimp